Treatment of an Opposing Metabolic Situation: GLUT1-Deficiency Syndrome and Type 1 Diabetes. [PDF]
Schoenlaub AK+7 more
europepmc +1 more source
Crossing the Blood-Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies. [PDF]
Ding L+3 more
europepmc +1 more source
DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis. [PDF]
Yin Q+9 more
europepmc +1 more source
Glycolysis regulates palatal mesenchyme proliferation through Pten-Glut1 axis via Pten classical and non-classical pathways. [PDF]
Wang Y+7 more
europepmc +1 more source
Erratum: Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation: Erratum. [PDF]
Lu YX+18 more
europepmc +1 more source
MYLIP attenuates hypoxia tolerance by inducing K27-linked polyubiquitination and subsequent proteasomal degradation of HIF-α. [PDF]
Li J+10 more
europepmc +1 more source
The relevance of resveratrol in ameliorating carotid atherosclerosis through glycolysis. [PDF]
Pan H+5 more
europepmc +1 more source
MLN4924 suppresses tumor metabolism and growth of clear cell renal cell carcinoma by stabilizing nuclear FBP1. [PDF]
Yang Y+10 more
europepmc +1 more source
Glucose Transporter 1 (GLUT1) Positivity in Ganglion Cysts: A Diagnostic Caveat Due to Overlap With Perineuriomas and Other Fibromyxoid Lesions. [PDF]
Lazim A, Malik F, Cooper K.
europepmc +1 more source